Pfizer Submits Covid-19 Pill for FDA Authorization
Pfizer Inc. said it asked U.S. health regulators to authorize its oral Covid-19 drug for use in high-risk patients, putting...
Biotechnology
Pfizer Says Covid-19 Pill Is 89% Effective in Preliminary Assessment
Pfizer Inc. said a preliminary look at study results found that its experimental pill was highly effective at preventing people...
Pfizer Ups Covid-19 Vaccine Forecast as Sales More Than Double
Pfizer Inc. raised its forecast for sales of its Covid-19 vaccine this year to about $36 billion, a roughly 7%...
Pfizer-BioNTech Covid-19 Vaccine for Young Kids Satisfied FDA Criteria, Agency Says
The Food and Drug Administration said the Covid-19 vaccine from Pfizer Inc. PFE 0.70% and BioNTech SE BNTX -2.80% met...
Moderna and J&J Covid-19 Boosters, Mixing and Matching Authorized by the FDA
U.S. health regulators significantly widened the nation’s Covid-19 booster campaign, clearing use of extra doses of Moderna Inc. and Johnson...
WSJ News Exclusive | FDA Delays Moderna Covid-19 Vaccine for Adolescents to Review Rare Myocarditis Side Effect
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -2.41% Covid-19 vaccine for adolescents to...
Covid-19 Booster Shot to Be Offered to Americans Fully Vaccinated With Pfizer, Moderna
The Biden administration took steps Wednesday to crack down on rising Covid-19 cases, including a call for a third shot...
